Dede Didem Şener - Department of Medical Oncology, Ankara Bilkent City Hospital

基本信息

浏览量：2

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 65 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Do Metastatic Volumes Measured in Breast Cancer Patients with Bone Metastases Correlate with the Numbers of Skeletal and Extraskeletal Events

Hilal Yagar,Mahmut Nedim Aytekin,Didem Sener Dede,Mehmet Ali Nahit Sendur,Recep Ozturk,Buelent Yalcin

JOINT DISEASES AND RELATED SURGERYno. 1 (2024): 105-111

引用0浏览0WOS引用

A Current Comprehensive Role of Immune-Checkpoint Inhibitors in Resectable Non-Small Cell Lung Cancer: A Narrative Review

Safa Can Efil,Burak Bilgin,Furkan Ceylan,Hilal Karakas,Irfan Karahan, Sema Nur Ozsan,Hakan Kosku,Sebnem Yaman,Muhammed Bulent Akinci,Didem Sener Dede,Buelent Yalcin,Mehmet Ali Nahit Sendur

Journal of oncology pharmacy practice official publication of the International Society of Oncology Pharmacy Practitionersno. 7 (2024): 1214-1239

引用0浏览0WOS引用

Should Clinical Trials about Prostate Cancer Assess the Frailty As an Endpoint

Irfan Karahan,Didem Sener Dede

International Urology and Nephrologyno. 7 (2023): 1729-1730

引用0浏览0引用

Unresectable Hepatocellular Carcinoma and Prognostic Factors of Sorafenib Treatment: A Real-Life Experience

Cihan EROL,Murat BARDAKÇI,Mutlu HIZAL,Seda KAHRAMAN,Emre Yekedüz,Deniz Can Güven,Musa Barış AYKAN,Recep Ak,Öztürk ATEŞ,Didem Şener Dede,Muhammed Bülent Akıncı,Nuri KARADURMUŞ,Öznur Bal,Yüksel ÜRÜN,Şuayib Yalçın,Bülent YALÇIN,Mehmet Ali Nahit ŞENDUR

Journal of oncological scienceno. 2 (2023): 72-78

引用0浏览0引用

Comparison of Adjuvant Modified FOLFIRINOX with Other Adjuvant Chemotherapies in Resected Pancreatic Adenocarcinoma: Real-life Data

Cihan Erol,Emre Hafızoğlu,Musa Barış Aykan,Deniz Can Güven,Bengü Dursun,Mutlu Hızal,Seda Kahraman,Didem Şener Dede,Muhammed Bülent Akıncı,Nuri Karadurmuş,Yüksel Ürün,Efnan Algın,Şuayib Yalçın,Bülent Yalçın,Mehmet Ali Nahit Şendur

Acta Oncologica Turcicano. 2 (2023): 170-179

引用0浏览0引用

The Relationship Between Adjuvant Chemotherapy and Thiol-Disulfide Compounds

Pinar Akyol,Didem Sener Dede,Burak Bilgin,Arife Ulas,Mehmet Ali Nahit Sendur,Muhammed Bulent Akinci,Salih Baser,Cihan Erol,Mutlu Hizal,Bulent Yalcin

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS（2022）

引用0浏览0WOS引用

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric and Gastroesophageal Junction Tumors: Real-Life Data (turkish Oncology Group)

Turkish journal of medical sciencesno. 4 (2022): 1022-1032

引用0浏览0WOS引用

Are Tyrosine Kinase Inhibitors As Effective As They Are Safe in Renal Cell Cancer Patients over the Age of 65

Arife Ulas,Fahriye Tugba Kos,Didem Sener Dede,Bulent Yalcin

The annals of clinical and analytical medicineno. 01 (2022)

引用0浏览0引用

Birinci Basamak Alektinib Tedavisi Alan ALK Mutasyonu Pozitif Akciğer Kanseri Hastalarının Klinik Özelliklerinin Değerlendirilmesi

Mutlu Hızal,Burak Bilgin,Mehmet Ali Şendur,Şebnem Yücel,Seda Kahraman,Cihan Erol,Bülent Akıncı,Didem Şener Dede,Efnan Algın,Bülent Yalçın

Tuberk Toraks（2021）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn